QSI logo

Quantum-Si Incorporated (QSI)

$1.37

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on QSI

Market cap

$301047107

EPS

-0.38

P/E ratio

--

Price to sales

208.66

Dividend yield

--

Beta

3.269958

Price on QSI

Previous close

$1.33

Today's open

$1.37

Day's range

$1.30 - $1.38

52 week range

$0.69 - $1.81

Profile about QSI

CEO

Jeffrey Hawkins

Employees

145

Headquarters

Branford, CT

Exchange

NASDAQ Global Market

Shares outstanding

219742414

Issue type

Common Stock

QSI industries and sectors

Healthcare

Biotechnology & Life Sciences

News on QSI

Quantum-Si Q3 Earnings Call Highlights

Quantum-Si NASDAQ: QSI reported lower third-quarter revenue and narrowed its net loss as it prepared for the planned second-quarter 2027 commercial launch of its Proteus protein sequencing platform.

news source

MarketBeat • Nov 6, 2026

news preview

Quantum-Si incorporated (QSI) Q3 2026 Earnings Call Transcript

Quantum-Si incorporated (QSI) Q3 2026 Earnings Call Transcript

news source

Seeking Alpha • Nov 6, 2026

news preview

Quantum-Si Reports Third Quarter 2026 Financial Results and Provides Business Update

BRANFORD, Conn., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule protein sequencing, today announced financial results for the third quarter ended September 30, 2026.

news source

GlobeNewsWire • Nov 5, 2026

news preview

Quantum-Si Incorporated (QSI) Reports Q3 Loss, Misses Revenue Estimates

Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.17 per share a year ago.

news source

Zacks Investment Research • Nov 6, 2026

news preview

Quantum-Si to Provide a Business Update and Report Third Quarter 2026 Financial Results on November 5, 2026

BRANFORD, Conn., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining protein analysis through single-molecule detection, today announced that it will provide a business update and report financial results for the third quarter 2026 on Thursday, November 5, 2026.

news source

GlobeNewsWire • Oct 16, 2026

news preview

Quantum-Si Regains Compliance with Nasdaq Minimum Bid Price Requirement

BRANFORD, Conn., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI,” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that it has received written notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq Global Market under Listing Rule 5450(a)(1).

news source

GlobeNewsWire • Oct 15, 2026

news preview

Leading Indicators For The October Breakout Cycle

Q4 historically delivers outsized S&P 500 returns, especially following midterm election years, supporting the 'October breakout cycle' thesis. Since 2000, the gains in the fourth quarter have averaged more than half of the S&P 500's annual returns with more positive years than all the other quarters. Small cap healthcare/biotech, technology, and consumer cyclicals—like PRME, CRNC, and FOSL—are highlighted as early breakout candidates with strong institutional interest and analyst targets.

news source

Seeking Alpha • Oct 11, 2026

news preview

Beyond Elon Musk's Neuralink: Two Public Stocks With a Stake in the Brain Race

Elon Musk's Neuralink is giving us a glimpse of a future in which the human brain can communicate directly with computers. For investors, there's just one problem: You can't buy Neuralink stock.

news source

InvestorPlace • Oct 9, 2026

news preview

Quantum-Si Demonstrates Detection of 19 Amino Acids in Proteus™ Development Program

BRANFORD, Conn., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics company redefining protein analysis through single-molecule protein sequencing, today announced that it has demonstrated detection of 19 amino acids in its Proteus™ development program and is now working to deploy that capability into a developmental sequencing kit for routine use on integrated Proteus instruments.

news source

GlobeNewsWire • Oct 8, 2026

news preview

Top 3 Health Care Stocks That May Collapse In Q4

As of Oct. 5, 2026, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

news source

Benzinga • Oct 5, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Quantum-Si Incorporated

Open an M1 investment account to buy and sell Quantum-Si Incorporated commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in QSI on M1